Article
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
The Lancet. Oncology - 1 Jan 2006
Rothman Nathaniel, Skibola Christine F, Wang Sophia S, Morgan Gareth, Lan Qing, Smith Martyn T, Spinelli John J, Willett Eleanor, De Sanjose Silvia, Cocco Pierluigi, Berndt Sonja I, Brennan Paul, Brooks-Wilson Angela, Wacholder Sholom, Becker Nikolaus, Hartge Patricia, Zheng Tongzhang, Roman Eve, Holly Elizabeth A, Boffetta Paolo, Armstrong Bruce, Cozen Wendy, Linet Martha, Bosch F Xavier, Ennas Maria Grazia, Holford Theodore R, Gallagher Richard P, Rollinson Sara, Bracci Paige M, Cerhan James R, Whitby Denise, Moore Patrick S, Leaderer Brian, Lai Agnes, Spink Charlotte, Davis Scott, Bosch Ramon, Scarpa Aldo, Zhang Yawei, Severson Richard K, Yeager Meredith, Chanock Stephen, Nieters Alexandra
Abstract excerpt
BACKGROUND: Common genetic variants in immune and inflammatory response genes can affect the risk of developing non-Hodgkin lymphoma. We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph). METHODS: We selected 12 single-nucleotide polymorphisms for analysis, on the basis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
